TIME Framework in Wound Care: A Systematic Assessment Approach
The TIME wound assessment framework — Tissue management, Infection/Inflammation control, Moisture balance, and Edge advancement for systematic wound evaluation and documentation.
Damon Ebanks
Medipyxis
TIME Framework in Wound Care FAQ
The TIME framework is a systematic approach to wound bed preparation developed by an international advisory board and published by Schultz et al. in 2003. It provides a structured method for assessing chronic wounds, identifying barriers to healing, and selecting interventions. Each letter represents one component of wound bed assessment: Tissue, Infection/Inflammation, Moisture, and Edge. The framework does not replace clinical judgment -- it organizes it, ensuring that every wound assessment addresses the four factors most likely to stall healing.
T -- Tissue: What tissue is present in the wound bed?
The first assessment step is identifying the tissue types present in the wound bed and determining whether nonviable tissue needs removal.
What to assess: The percentage of the wound bed covered by viable tissue (granulation, epithelial) versus nonviable tissue (necrotic/eschar, slough, fibrin). A wound bed dominated by black eschar or yellow slough is not ready to heal -- devitalized tissue provides a substrate for bacterial growth, maintains chronic inflammation, and physically blocks epithelial cell migration.
Clinical action: Debride nonviable tissue to create a wound bed that supports healing. The debridement method -- sharp, autolytic, enzymatic, mechanical, or biological -- is selected based on tissue type, wound location, patient tolerance, and clinical setting. In mobile wound care, sharp and autolytic debridement are the most commonly performed methods.
Documentation requirement: Describe the tissue types present as percentages (e.g., "wound bed 60% granulation, 30% fibrinous slough, 10% adherent eschar"), the debridement method used, the tissue removed, and the deepest tissue layer reached. This documentation directly supports debridement CPT code selection. For debridement code specifics, see our debridement billing guide.
I -- Infection and Inflammation: Is the wound infected or chronically inflamed?
The second component assesses bacterial burden and inflammatory status -- two related but distinct problems.
What to assess: Clinical signs of infection (increasing pain, erythema extending >2 cm from wound margins, purulent drainage, warmth, wound deterioration, malodor) versus signs of chronic subclinical inflammation (stalled healing without overt infection signs, friable granulation tissue that bleeds easily, increased exudate without classical infection indicators).
Infection vs. colonization vs. biofilm: All chronic wounds are colonized by bacteria. Colonization alone does not require treatment. Clinical infection -- bacteria causing tissue damage and systemic response -- requires systemic antibiotics. Biofilm -- organized bacterial communities maintaining chronic inflammation without overt infection -- requires debridement and topical antimicrobials, not systemic antibiotics. The treatment depends entirely on which category the wound falls into.
Clinical action: For clinical infection, systemic antibiotics guided by culture and sensitivity. For biofilm or critical colonization, sharp debridement combined with antimicrobial dressings (silver, cadexomer iodine, PHMB). For chronic inflammation without infection, address underlying causes -- foreign bodies, repeated trauma, uncontrolled edema, or inadequate perfusion.
Documentation requirement: Document the specific signs present or absent, culture results when obtained, and the clinical rationale for the antimicrobial approach chosen. "No signs of infection" is insufficient -- document which signs were assessed and found negative.
M -- Moisture: Is the wound moisture balance appropriate?
The third component evaluates whether the wound environment is too wet, too dry, or appropriately balanced.
What to assess: Exudate volume (none, scant, moderate, copious), exudate character (serous, sanguineous, serosanguineous, purulent), and the condition of the periwound skin. A wound that is too dry desiccates the wound bed and impedes cell migration. A wound that is too wet macerates the periwound skin, enlarges the wound, and increases infection risk.
Clinical action: Select dressings that maintain moisture balance. Dry wounds need moisture-donating dressings (hydrogels, honey-based dressings). Heavily exudative wounds need absorptive dressings (alginates, hydrofibers, foam dressings). The correct dressing changes as the wound progresses -- a wound that initially produces copious exudate may need a moisture-donating dressing once granulation is established and exudate decreases.
Documentation requirement: Document exudate volume and character at each visit, periwound skin condition (intact, macerated, desiccated, erythematous), and the dressing selected with rationale tied to the moisture assessment. Dressing changes that do not correspond to documented moisture findings raise audit questions.
E -- Edge: Are the wound edges advancing?
The fourth component assesses whether the wound is actively closing and identifies barriers at the wound margin.
What to assess: Epithelial advancement from wound edges (a sign of active healing), rolled or epibole edges (epithelial cells have curled under, forming a physical barrier to wound closure), undermining or tunneling (tissue destruction extending beneath intact skin at the wound margin), and wound size trajectory over time.
Clinical action: Rolled edges require debridement to remove the epibole and re-expose the wound edge to the wound bed. Undermining and tunneling require packing to prevent premature surface closure over dead space. If wound edges are not advancing despite adequate tissue management, infection control, and moisture balance, reassess for systemic barriers -- nutritional deficiency, uncontrolled diabetes, vascular insufficiency, or medication effects (corticosteroids, immunosuppressants).
Documentation requirement: Record wound measurements (length, width, depth) at every visit using a consistent method. Document the presence or absence of undermining and tunneling with location and depth. The healing trajectory over time -- demonstrated by serial measurements -- is the primary evidence that treatment is effective and continued intervention is medically necessary. For pressure injury-specific edge assessment, see our pressure injury staging guide.
How does TIME guide treatment decisions and documentation?
TIME is not a one-time assessment. It is applied at every visit, and the findings drive the treatment plan for that visit. A wound that was moisture-balanced last week may be overly exudative this week due to increased bioburden. A wound with advancing edges may develop rolled margins if a tissue barrier forms.
The framework's documentation value is equally important: by systematically recording tissue status, infection/inflammation assessment, moisture balance, and edge advancement at each visit, the clinician builds a longitudinal record that demonstrates medical necessity for continued treatment, supports the CPT codes selected, and withstands audit review. A note that addresses all four TIME components contains the elements auditors look for -- wound bed description, infection assessment, dressing rationale, and measurable healing trajectory.